[5] JIM B， GHANTA M， QIPO A， et al. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes：a cross sectional study[J]. PLoS One，2012，7(5)：e36041.
[6] CHEN J， CHEN Y， LUO Y， et al. Astragaloside Ⅳ ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats[J]. Eur J Pharmacol，2014， 736：86-94.
[7] GUI D， WEI L， JIAN G， et al. Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo[J]. Cell Physiol Biochem，2014，34(6)：1849-1862.
[8] 王旭焘，潘定一，郭玮，等.阿魏酸对糖尿病大鼠肾脏足细胞nephrin、podocin蛋白表达的影响[J].中国应用生理学杂志，2017，33(6)：564- 567.
[9] DAI H， LIU Q， LIU B. Research progress on mechanism of podocyte depletion in diabetic nephropathy[J]. J Diabetes Res，2017，2017：2615286.
[10] LEE S H， MOON S J， PAENG J， et al. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions[J]. Apoptosis， 2015，20(8)：1056-1071.
[11] MUKHI D， NISHAD R， MENON R K， et al. Novel actions of growth hormone in podocytes：implications for diabetic nephropathy[J]. Front Med (Lausanne)，2017，4：102.
[12] 郭维文，廖水玉，李佑生.小檗碱对高糖诱导的小鼠足细胞凋亡的影响[J].上海中医药杂志，2017，51(11)：68-71.
[13] SUN L N， LIU X C， CHEN X J， et al. Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS[J]. Acta Pharmacol Sin，2016，37(5)：645-655.
[14] 李艷，秦洁，张姬欣，等.高糖、高同型半胱氨酸致足细胞内质网应激时白藜芦醇对CHOP通路的影响[J].中华临床医师杂志(电子版)，2014， 8(3)：481-484.
[15] GUO H， CAO A， CHU S， et al. Astragaloside Ⅳ attenuates podocyte apoptosis mediated by endoplasmic reticulum stress through upregulating sarco/endoplasmic reticulum Ca2+-ATPase 2 expression in diabetic nephropathy[J]. Front Pharmacol，2016，7：500.
[16] RANI V， DEEP G， SINGH R K， et al. Oxidative stress and metabolic disorders：Pathogenesis and therapeutic strategies[J]. Life Sci， 2016，148(1)：183-193.
[17] BHATTI A B， USMAN M. Drug targets for oxidative podocyte injury in diabetic nephropathy[J]. Cureus，2015，7(12)：e393., 百拇医药(宫彩霞 王志强)